Clinical Trial Update: Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PD-1Ab21-BCMA CAR-T therapy as consolidation for multiple myeloma with renal dysfunction; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• PD-1Ab21-BCMA CAR-T Therapy

Snippet

Sponsor: Daihong Liu | Conditions: Multiple Myeloma | Phase 2 | Status: RECRUITING